Skip to main content
Premium Trial:

Request an Annual Quote

Genomica Plans Update To Discovery Manager

Premium

BOULDER, Colo.--Genomica, a gene discovery and drug development bioinformatics tools company here, has announced plans to release a new version of its Discovery Manager software next month. The existing product includes visualization and analysis tools and includes a genetics database collected from numerous sources and integrated through semantic normalization, a process that merges diversely represented data into a common model to allow researchers to exploit complex relationships among sets of genetic information.

New features of the upcoming Version 2.1.0 include a marker manager to allow users to generate graphs and reports comparing the frequency of genetic markers of interest in different populations and subject clusters; a conditional pipeline for sequence analysis that allows high-throughput screening of multiple DNA sequences against a large selection of user-specified databases through complex decision-tree pipelines; an advanced query tool for highly complex queries using any type of data within the system; and enhanced inheritance-checking tools for internal and advanced third-party inheritance-checking programs.

Filed under

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.